Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vote in favor of Your #1 sort of pie - 2Taylor Swift just released the 'Elizabeth Taylor' music video — but she's not the star of it
- 3Syrian army says recent drone attacks targeted its bases near Iraq, most shot down
- 4The most effective method to Guarantee Simple Availability in Seniors' SUVs
- 5Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
- Vote in favor of Your Number one kind of pie
- Jasmine Crockett in, Colin Allred out: A major shakeup for Democrats in their quest to finally win a Senate seat in Texas
- General Atlantic says ‘biggest mistake’ would be pulling back on Gulf deals
- Israeli Chief of Staff declares new border with Gaza Strip
- Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
- Polish law aimed at lowering petrol prices takes effect
- What's going around right now? COVID, flu, stomach bug on the rise
- The Most Notable Design Brands of the 21st Hundred years
- German foreign minister heads to China to talk rare-earth exports
